Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (Coast-AF) Randomized Clinical Trial

NCT03347227 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.

NCT NCT03347227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03347227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (Coast-AF) Randomized Clinical Trial
Lead sponsor
Ottawa Heart Institute Research Corporation
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 24, 2018
Completion date
December 31, 2027
Enrollment
510 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation